VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
OCU200
Phase 1
Small molecule
O
Ocugen
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Center Involved Diabetic Macular Edema
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Center Involved Diabetic Macular Edema
Phase 1
Recruiting
Clinical
Trials by Indication
[1]
Center Involved Diabetic Macular Edema
1 trial
A Phase 1 Study To Assess The Safety And Efficacy Of OCU200 For Center-Involved Diabetic Macular Edema
Recruiting
·
O
Ocugen
·
Phase 1
·
NCT05802329
·
24 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for OCU200. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
OCU200 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for OCU200. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Ocugen company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
O
Ocugen
Related News